Scientific Sessions

Dr. Todd BullPH Around the World

At the Scientific Sessions at PHA’s International PH Conference, researchers and healthcare professionals will have the opportunity to engage in educational sessions about PH practice and cutting-edge research. The theme of PHA’s 2016 Scientific Sessions is PH Around the World, and presentations will discuss the differences in the diagnosis, epidemiology, pathophysiology, and medical management of PH and PAH between developed and developing regions in order to facilitate the development and dissemination of novel treatment strategies for these conditions.

Learning Objectives

After participating in this activity, participants will be able to:

  1. Describe individual characteristics of specific causes
    of PH worldwide.
  2. Discuss if and how interventions successfully used in the
    Western world can be applied in the developing world.
  3. Discuss how to leverage successes and failures in PH
    research over the past 25 years for the development
    of novel therapies and treatments.

Preliminary Scientific Sessions Schedule and Speakers

Thursday, June 16, 2016

Scientific Sessions Poster Hall Reception
Join your colleagues to view abstracts in the poster hall.
Heavy hors d’oeuvres and drinks will be served.

PH Professional Network Dinner
Nurses, nurse practitioners, respiratory therapists, pharmacists, physician assistants, social workers and other non-physician clinicians play a tremendous role in the care and treatment of PH patients. Join the PH Professional Network for a members-only dinner for colleagues to reconnect and celebrate the contributions they make to the PH community.

Friday, June 17, 2016

What has happened in the last 25 years: Global Perspectives/20 Years of Prostacyclins
Vallerie McLaughlin, MD, University of Michigan

Oral Abstract Presentation: 1002: PHD2 deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension recapitulating clinical PAH
Zhiyu Dai, PhD, University of Illinois College of Medicine, USA

What Have We Learned from Modern Worldwide Registries?
David Badesch, MD, FACP, University of Colorado Denver

Oral Abstract Presentation: 1010: A selective TGFβ ligand trap attenuates pulmonary arterial hypertension
Dr. Lai-Ming Yung, Brigham and Women’s Hospital, USA

Etiologies of PH Across the World - Schistosomiasis
Ghazwan Butrous, MD, PhD, University of Kent

Etiologies of PH Across the World - HIV
Christopher Barnett, MD, MPH, University of California San Francisco

Etiologies of PH Across the World - Drugs and Toxins
Vinicio de Jesus Perez, MD, Stanford University

Etiologies of PH Across the World - High Altitude
Erik Swenson, MD, University of Washington

Oral Abstract Presentation: 1051: Evidence of Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension
Evan L. Brittain, MD, MSCI, Vanderbilt University, USA

Panel Discussion: Enhancing Access to Drugs in Developing Countries, Challenges of Making Generic Drugs Available in Developing Countries
Steven Kawut, MD, MS, University of Pennsylvania
Mona Selej, MD, Actelion Pharmaceuticals
Ghazwan Butrous, MD, PhD, University of Kent
Professor Talant M. Sooronbaev, MD, Central Asia Pulmonary Hypertension (CAPH) PVRI Task Force

Oral Abstract Presentation: 1042: A computer simulation model for atrial fenestration sizing in pulmonary arterial hypertension with right ventricular failure
Joseph Kuruvilla, DO, Helen DeVos Children’s Hospital of Spectrum Health, USA

Salvage Therapies in the U.S. and Europe versus Elsewhere
Corey Ventetuolo, MD, MS, Brown University
Tomas Pulido, MD, Instituto Nacional de Cardiologia

Rethinking Pediatric PH -- International Aspects
Eric Austin, MD, MSCI, Vanderbilt University

From Bench to Bedside: Which Novel Pathways are Most Likely to be Harnessed Therapeutically in the Next 25 Years?
Prof. Martin Wilkins, Imperial College London

 



PHA thanks the sponsors of the International PH Conference and Scientific Sessions:

Diamond:

Actelion Bayer Gilead

Platinum:

 

Silver:

Accredo Specialty Pharmacy Reata Pharmaceuticals United Therapeutics logo

Bronze:

SteadyMed Therapeutics

General:

Bellerophon TherapeuticsEiger BioPharmaceuticals


To support the International PH Conference and Scientific Sessions, please visit the sponsorship page.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of PHAssociation.org, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.